- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Updates in Pediatric Atopic Dermatitis : Episode 7
Opinion
Video
New Nonsteroid Topical Treatments for Pediatric Atopic Dermatitis: Topical Roflumilast
Panelists discuss the topical treatment option roflumilast for pediatric atopic dermatitis, exploring its mechanism of action, efficacy, safety, and potential role in managing the condition.
Video Player is loading.
Video content above is prompted by the following:
Now let’s talk about some of the latest treatment advances in pediatric atopic dermatitis, starting with topicals. Discuss the topical treatment options that are newly available or on the horizon, including how they work to treat atopic dermatitis as well as efficacy and safety:
- Roflumilast
Related Videos
Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma
Differentiating Between JAK Inhibitors in Clinical Practice
IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
Clinical Attributes of IL-17 Inhibitors in Psoriasis
Challenges and Unmet Needs in Treating Pediatric Atopic Dermatitis
Laboratory Monitoring with Oral JAK Inhibitors
Gene Expression Profiling and Other Molecular Tests Utilized for Melanoma and Squamous Cell Carcinoma
Talking to Patients on Sunscreen Application and the Effects of Visible Light
Clinical Experience and Diagnosis of GPP
The Prevalence and Characteristics of GPP
Related Content
